100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Delivery Order 75N93018D00002-75N93020F00003
Award Date
3/30/20
Potential Completion Date
7/31/20
Potential Value
$54K
Overview
Contacts
Activity
2
Transactions
2
Subawards
Opportunity Stack
Similar Awards
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Research Triangle Institute JJHCMK4NT5N3
Ultimate Awardee
Not listed
NAICS Category
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Category
AN11 - Health R&D Services; Health Care Services; Basic Research
Federal Contract Vehicle
Nonclinical Services for Development of Interventional Agents
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Nonclinical Services for Development of Interventional Agents
Master IDIQ
75N93018D00002
Indefinite Delivery Contract
75N93018D00002-75N93020F00003
Delivery Order
Update #1
Update #2
NON-CLINICAL SERVICES FOR DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES
Posted 3/30/20
5
1
Name
Description
Solicitation Number
FederalAgency
Type
PostedDate
Nonclinical Services for Development of Interventional Agents for Infectious Diseases
Added: Feb 13, 2017 2:45 pm Research supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), strives to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that teaten millions of human lives. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research for the investigation, control and prevention of diseases caused by all infectious agents other than HIV. Support for basic and applied research to develop and evaluate therapeutics, vaccines, and diagnostics is provided tough a variety of research grants and contracts. DMID also supports an array of research resources and services to assist investigators, including programs that provide or make available genomic data and technologies; organisms and state-of-the-art reagents; biocontainment facilities; and preclinical and clinical translational research services (http://www3.niaid.nih.gov/research/resources/dmid).The development and introduction of new therapeutic products against potential agents of bioterrorism, drug-resistant pathogens, emerging and re-emerging infectious diseases, as well as infectious diseases prevalent in resource-limited countries remain a high public health priority. To assist in filling these public health gaps, the NIAID requires a nontraditional, proactive, and product development-oriented program to provide preclinical and non-clinical development support for promising therapeutic candidates that emerge from academia, the private sector, or other sources. The suite of services will encompass those activities commonly associated with the development of interventional products for infectious disease required for New Drug Application (NDA), Biologic License Applications (BLA) and/or Investigational New Drug (IND) applications. Consequently, DMID recognizes that to obtain the full spectrum of expertise or facilities required to perform all activities set forth in this solicitation, individual organizations will likely need the expertise and resources of other organizations or persons tough consortia agreements, partnerships, subcontracts, and/or consultants.
NIHAI2017090
Department of Health and Human Services National Institutes of Health
Award Notice 1/1
2/13/17, 2:45 PM
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
P00001
NON-CLINICAL SERVICES FOR DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES
Other Administrative Action
$0
5/28/20
Not listed
NON-CLINICAL SERVICES FOR DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES
Not listed
$53.6k
3/30/20